The CCRA welcomes Dr. Lucille Beaudet

Modified on

Newest CCRA member, Dr. Lucille Beaudet, joins us from the Cancer Research Society where she assumed the position of Scientific Advisor in September 2014. Dr. Beaudet brings a vast knowledge of various drug discovery platforms, and she led the development and commercialization of a large numbers of products used in the discovery of new treatments for cancers and other complex diseases. Her basic and applied research background is complemented with an MBA. We look forward to her involvement in the CCRA!